Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2017

Open Access 01-12-2017 | Research article

Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients

Authors: Erin M. Bauer, Ami Ben-Artzi, Erin L. Duffy, David A. Elashoff, Sitaram S. Vangala, John Fitzgerald, Veena K. Ranganath

Published in: BMC Musculoskeletal Disorders | Issue 1/2017

Login to get access

Abstract

Background

Clinical swollen joint examination of the obese rheumatoid arthritis (RA) patient can be difficult. Musculoskeletal Ultrasound (MSUS) has higher sensitivity than physical examination for swollen joints (SJ). The purpose of this study was to determine the joint-specific association between power Doppler (PDUS) and clinical SJ in RA across body mass index (BMI) categories.

Methods

Cross-sectional clinical and laboratory data were collected on 43 RA patients. PDUS was performed on 9 joints (wrist, metacarpalphalangeal 2–5, proximal interphalgeal 2/3 and metatarsalphalangeal 2/5). DAS28 and clinical disease activity index (CDAI) were calculated. Patients were categorized by BMI: <25, 25–30, and >30. Demographic and clinical characteristics were compared across BMI groups with Kruskal-Wallis test and chi-square tests. Joint-level associations between PDUS and clinically SJ were evaluated with mixed effects logistic regression models.

Results

While demographics and clinically-determined disease activity were similar among BMI groups, PDUS scores significantly differed (p = 0.02). Using PDUS activity as the reference standard for synovitis and clinically SJ as the test, the positive predictive value of SJ was significantly lower in higher BMI groups (0.71 in BMI < 25, 0.58 in BMI 25–30 and 0.44 in BMI < 30) (p = 0.02). The logistic model demonstrated that increased BMI category resulted in decreased likelihood of PDUS positivity (OR 0.52, p = 0.03).

Conclusions

This study suggests that in an obese RA patient, a clinically assessed SJ is less likely to represent true synovitis (as measured by PDUS). Disease activity in obese RA patients may be overestimated by CDAI/DAS28 calculations and clinicians when considering change in therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference McAlindon T, Kissin E, Nasarian L, Ranganath V, Prakash S, Taylor M, et al. American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care Res. 2012;64:1625–40.CrossRef McAlindon T, Kissin E, Nasarian L, Ranganath V, Prakash S, Taylor M, et al. American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care Res. 2012;64:1625–40.CrossRef
2.
go back to reference Colebatch AN, Edwards CJ, Ostergaard M, van der Heijde D, Balint PV, D-Agostino MA, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72:804–14.CrossRefPubMed Colebatch AN, Edwards CJ, Ostergaard M, van der Heijde D, Balint PV, D-Agostino MA, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72:804–14.CrossRefPubMed
3.
go back to reference Rowbotham E, Grainger A. Rheumatoid arthritis: Ultrasound vs. MRI. AJR. 2001;197:541–6.CrossRef Rowbotham E, Grainger A. Rheumatoid arthritis: Ultrasound vs. MRI. AJR. 2001;197:541–6.CrossRef
4.
go back to reference Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D’Agostino MA, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32:2485–7.PubMed Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D’Agostino MA, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32:2485–7.PubMed
5.
go back to reference Backhaus M, Ohrndorf S, Kellner H, Strunk J, Backhaus TM, Hartung W, et al. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum. 2009;61:1194–201.CrossRefPubMed Backhaus M, Ohrndorf S, Kellner H, Strunk J, Backhaus TM, Hartung W, et al. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum. 2009;61:1194–201.CrossRefPubMed
6.
go back to reference Hama M, Uehara T, Takase K, Ihata A, Ueda A, Takeno M, et al. Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data. Rheumatol Int. 2012;32:1327–33.CrossRefPubMed Hama M, Uehara T, Takase K, Ihata A, Ueda A, Takeno M, et al. Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data. Rheumatol Int. 2012;32:1327–33.CrossRefPubMed
7.
go back to reference Taylor PC, Steuer A, Gruber J, McClinton C, Cosgrove DO, Blomley MJ, et al. Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one year delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. Arthritis Rheum. 2006;54:47–53.CrossRefPubMed Taylor PC, Steuer A, Gruber J, McClinton C, Cosgrove DO, Blomley MJ, et al. Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one year delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. Arthritis Rheum. 2006;54:47–53.CrossRefPubMed
8.
go back to reference Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis. 2005;64:375–81.CrossRefPubMedPubMedCentral Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis. 2005;64:375–81.CrossRefPubMedPubMedCentral
9.
go back to reference Foltz V, Gandjbakhch F, Etchepare F, Rosenberg C, Tanguy ML, Rozenberg S, et al. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum. 2012;64:67–76.CrossRefPubMed Foltz V, Gandjbakhch F, Etchepare F, Rosenberg C, Tanguy ML, Rozenberg S, et al. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum. 2012;64:67–76.CrossRefPubMed
10.
go back to reference Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 2008;59:807–15.CrossRefPubMedPubMedCentral Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 2008;59:807–15.CrossRefPubMedPubMedCentral
11.
go back to reference Labitigan M, Bahce-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, et al. Higher rates and clustering of abnormal lipids, obesity, and diabetes in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res. 2014;66:600–7.CrossRef Labitigan M, Bahce-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, et al. Higher rates and clustering of abnormal lipids, obesity, and diabetes in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res. 2014;66:600–7.CrossRef
12.
go back to reference Garcia-Poma A, Segami MI, Mora CS, Ugarte MF, Terrazas HN, Rhor EA, et al. Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis. Clin Rheumatol. 2007;26:1831–5.CrossRefPubMed Garcia-Poma A, Segami MI, Mora CS, Ugarte MF, Terrazas HN, Rhor EA, et al. Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis. Clin Rheumatol. 2007;26:1831–5.CrossRefPubMed
13.
go back to reference Rodrigues AM, Reis JE, Santos C, Pereira MP, Loureiro C, Martins F, et al. A1.1 Obesity is a risk factor for worse treatment response in rheumatoid arthritis patients- results from reuma.pt. Ann Rheum Dis. 2014;73 Suppl 1:A1. Rodrigues AM, Reis JE, Santos C, Pereira MP, Loureiro C, Martins F, et al. A1.1 Obesity is a risk factor for worse treatment response in rheumatoid arthritis patients- results from reuma.pt. Ann Rheum Dis. 2014;73 Suppl 1:A1.
14.
go back to reference Klaasen R, Wijbrandts CA, Gerlag DM, Tak PP. Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis Rheum. 2011;63:359–64.CrossRefPubMed Klaasen R, Wijbrandts CA, Gerlag DM, Tak PP. Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis Rheum. 2011;63:359–64.CrossRefPubMed
15.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 Revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 Revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.CrossRefPubMed
16.
go back to reference Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Binghman C, et al. 2010 Rheumatoid arthritis classification criteria: An Aerican College of Rheumatology/European League Against Rheumatism collaborative initative. Arthritis Rheum. 2010;62:2569–81.CrossRefPubMed Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Binghman C, et al. 2010 Rheumatoid arthritis classification criteria: An Aerican College of Rheumatology/European League Against Rheumatism collaborative initative. Arthritis Rheum. 2010;62:2569–81.CrossRefPubMed
17.
go back to reference Hammer HB, Bolton-King P, Bakkeheim V, Berg TH, Sundt E, Kongtorp AK, et al. Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:1995–8.CrossRefPubMed Hammer HB, Bolton-King P, Bakkeheim V, Berg TH, Sundt E, Kongtorp AK, et al. Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:1995–8.CrossRefPubMed
18.
go back to reference Sandberg MEC, Bengtsson C, Kallberg H, Wesley A, Klareskog L, Alfredsson L, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2014;73:2029–33.CrossRefPubMed Sandberg MEC, Bengtsson C, Kallberg H, Wesley A, Klareskog L, Alfredsson L, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2014;73:2029–33.CrossRefPubMed
19.
go back to reference Smolen J, Aletaha A, Bijlsma J, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631–37.CrossRefPubMedPubMedCentral Smolen J, Aletaha A, Bijlsma J, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631–37.CrossRefPubMedPubMedCentral
20.
go back to reference Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, et al. Triple Therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum. 2008;58:1310–7.CrossRefPubMed Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, et al. Triple Therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum. 2008;58:1310–7.CrossRefPubMed
21.
go back to reference Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial. Lancet. 2004;364:263–9.CrossRefPubMed Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial. Lancet. 2004;364:263–9.CrossRefPubMed
22.
go back to reference Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology. 2010;49:424–8.CrossRef Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology. 2010;49:424–8.CrossRef
23.
go back to reference Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, et al. Association of concomitant fibromyalgia with worse Disease Activity Score n 28 joints, Health Assessment Questionnaire and Short Form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum. 2009;61:794–800.CrossRefPubMed Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, et al. Association of concomitant fibromyalgia with worse Disease Activity Score n 28 joints, Health Assessment Questionnaire and Short Form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum. 2009;61:794–800.CrossRefPubMed
24.
go back to reference Heimans L, van den Broek M, le Cessie S, Siegerink B, Riyazi N, Han KH, et al. Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients. Arthritis Care Res. 2013;65:1235–42.CrossRef Heimans L, van den Broek M, le Cessie S, Siegerink B, Riyazi N, Han KH, et al. Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients. Arthritis Care Res. 2013;65:1235–42.CrossRef
25.
go back to reference Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, et al. Obesity and reduction of the response rate to anti-tumor necrosis factor alpha in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res. 2013;65:94–100.CrossRef Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, et al. Obesity and reduction of the response rate to anti-tumor necrosis factor alpha in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res. 2013;65:94–100.CrossRef
26.
go back to reference Ajeganova S, Andersson ML, Hafstrom I. Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. Arthritis Care Res. 2013;65:78–87.CrossRef Ajeganova S, Andersson ML, Hafstrom I. Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. Arthritis Care Res. 2013;65:78–87.CrossRef
27.
go back to reference Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Nevill AM, Jamurtas AZ, Koutedakis Y, et al. Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clinical Rheumatol. 2009;28:439–44.CrossRef Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Nevill AM, Jamurtas AZ, Koutedakis Y, et al. Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clinical Rheumatol. 2009;28:439–44.CrossRef
28.
go back to reference Uutela T, Kautiainen H, Jarvenpaa S, Salomaa S, Hakala M, Hakkinen A. Waist circumference based abdominal obesity may be helpful as a marker for unmet needs in patients with RA. Scand Journal Rheumatol. 2014;43:279–85.CrossRef Uutela T, Kautiainen H, Jarvenpaa S, Salomaa S, Hakala M, Hakkinen A. Waist circumference based abdominal obesity may be helpful as a marker for unmet needs in patients with RA. Scand Journal Rheumatol. 2014;43:279–85.CrossRef
29.
go back to reference Baker J, George M, Baker D, Toedter G, Von Felt JM, Leonard MB. Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis. Rheumatology. 2011;50:2100–7.CrossRefPubMed Baker J, George M, Baker D, Toedter G, Von Felt JM, Leonard MB. Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis. Rheumatology. 2011;50:2100–7.CrossRefPubMed
30.
go back to reference van der Helm-van Mil AHM, van der Kooij SM, Allaart CF, Toes REM, Huizinga TWJ. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis. 2008;67:769–74.CrossRefPubMed van der Helm-van Mil AHM, van der Kooij SM, Allaart CF, Toes REM, Huizinga TWJ. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis. 2008;67:769–74.CrossRefPubMed
31.
go back to reference Kaufmann J, Kielstein V, Killian S, Stein G, Hein G. Relation Between Body Mass Index and Radiological Progression in Patients with Rheumatoid Arthritis. J Rheumatol. 2003;30:2350–5.PubMed Kaufmann J, Kielstein V, Killian S, Stein G, Hein G. Relation Between Body Mass Index and Radiological Progression in Patients with Rheumatoid Arthritis. J Rheumatol. 2003;30:2350–5.PubMed
32.
go back to reference Giles JT, Allisone M, Bingham III CO, Scott Jr WM, Bathon JM. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum. 2009;61:1248–56.CrossRefPubMedPubMedCentral Giles JT, Allisone M, Bingham III CO, Scott Jr WM, Bathon JM. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum. 2009;61:1248–56.CrossRefPubMedPubMedCentral
33.
go back to reference Baker J, Ostergaard M, Geroge M, Justine S, Emery P, Baker DG, et al. Greater Body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years. Ann Rheum Dis. 2014;73:1923–8.CrossRefPubMedPubMedCentral Baker J, Ostergaard M, Geroge M, Justine S, Emery P, Baker DG, et al. Greater Body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years. Ann Rheum Dis. 2014;73:1923–8.CrossRefPubMedPubMedCentral
34.
go back to reference Naredo E, Moller I, Cruz A, Carmona L, Garrido J. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2008;58:2248–56.CrossRefPubMed Naredo E, Moller I, Cruz A, Carmona L, Garrido J. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2008;58:2248–56.CrossRefPubMed
35.
go back to reference Haavardsholm EA, Aga A, Olsen IC, Lillegraven S, Hammer HB, Uhlig T, et al. Ultrasound in management of rheumatoid arthritis: ARCTIC randomized controlled strategy trial. BMJ. 2016;354:i4205.CrossRefPubMedPubMedCentral Haavardsholm EA, Aga A, Olsen IC, Lillegraven S, Hammer HB, Uhlig T, et al. Ultrasound in management of rheumatoid arthritis: ARCTIC randomized controlled strategy trial. BMJ. 2016;354:i4205.CrossRefPubMedPubMedCentral
36.
go back to reference Dale J, Stirling A, Zhang R, Purves D, Foley J, Sambrook M, Conaghan PG, et al. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomized clinical trial. Ann Rheum Dis. 2016;75:1043–50.CrossRefPubMed Dale J, Stirling A, Zhang R, Purves D, Foley J, Sambrook M, Conaghan PG, et al. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomized clinical trial. Ann Rheum Dis. 2016;75:1043–50.CrossRefPubMed
38.
go back to reference Wittoek R, Jens L, Lambrecht V, Carron P, Verstraete K, Verbruggen G. Reliability and construct validity of ultrasound of soft tissues and destructive changes in erosive osteoarthritis of the interphalangeal finger joints: a comparison with MRI. Ann Rheum Dis. 2011;20:278–83.CrossRef Wittoek R, Jens L, Lambrecht V, Carron P, Verstraete K, Verbruggen G. Reliability and construct validity of ultrasound of soft tissues and destructive changes in erosive osteoarthritis of the interphalangeal finger joints: a comparison with MRI. Ann Rheum Dis. 2011;20:278–83.CrossRef
39.
go back to reference Backhaus M, Kamradt T, Sandrock D, Loreck D, Fritz J, Wolf KJ, et al. Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum. 1999;42:1232–45.CrossRefPubMed Backhaus M, Kamradt T, Sandrock D, Loreck D, Fritz J, Wolf KJ, et al. Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum. 1999;42:1232–45.CrossRefPubMed
Metadata
Title
Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients
Authors
Erin M. Bauer
Ami Ben-Artzi
Erin L. Duffy
David A. Elashoff
Sitaram S. Vangala
John Fitzgerald
Veena K. Ranganath
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2017
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-017-1406-7

Other articles of this Issue 1/2017

BMC Musculoskeletal Disorders 1/2017 Go to the issue